Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2350)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4746)
  2. Department of Medicine (4744)
  3. Center for Pancreatic Cancer Research (2313)
  4. Surgery (1066)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (221)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (321)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4746)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Are financial payments from the pharmaceutical industry associated with physician prescribing? A systematic review
    Review

    Mitchell, A. P.; Trivedi, N. U.; Gennarelli, R. L.; Chimonas, S.; Tabatabai, S. M.; Goldberg, J.; Diaz, L. A. Jr; Korenstein, D.
    Annals of Internal Medicine (2021)

    Fulltext@MSK | Save
  • Introductions to the community: Early-career researchers in the time of COVID-19
    Miscellaneous

    Ganesh, K.; Patel, J.; Orlova, V. V.; Gifford, C.; Elias, S.; Vaughan, A.
    Cell Stem Cell (2021)

    Fulltext@MSK | Save
  • Dermatologic adverse events associated with selective fibroblast growth factor receptor inhibitors: Overview, prevention, and management guidelines
    Review

    Lacouture, M. E.; Sibaud, V.; Anadkat, M. J.; Kaffenberger, B.; Leventhal, J.; Guindon, K.; Abou-Alfa, G.
    The Oncologist (2021)

    Fulltext@MSK | Save
  • Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer
    Journal Article

    Sihag, S.; Ku, G. Y.; Tan, K. S.; Nussenzweig, S.; Wu, A.; Janjigian, Y. Y.; Jones, D. R.; Molena, D.
    Journal of Thoracic and Cardiovascular Surgery (2021)

    Fulltext@MSK | Save
  • Getting chemotherapy directly to the liver: The historical evolution of hepatic artery chemotherapy
    Review

    Anteby, R.; Kemeny, N. E.; Kingham, T. P.; D'Angelica, M. I.; Wei, A. C.; Balachandran, V. P.; Drebin, J. A.; Brennan, M. F.; Blumgart, L. H.; Jarnagin, W. R.
    Journal of the American College of Surgeons (2021)

    Fulltext@MSK | Save
  • Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials
    Journal Article

    Lopes, G. S.; Tournigand, C.; Olswold, C. L.; Cohen, R.; Kempf, E.; Saltz, L.; Goldberg, R. M.; Hurwitz, H.; Fuchs, C.; de Gramont, A.; more...
    Clinical Trials (2021)

    Fulltext@MSK | Save
  • Electronic rapid fitness assessment identifies factors associated with adverse early postoperative outcomes following radical cystectomy
    Journal Article

    Chesnut, G. T.; Tin, A. L.; Sjoberg, D. D.; Jang, B.; Benfante, N.; Sarraf, S.; Herr, H.; Donat, S. M.; Dalbagni, G.; Bochner, B.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • Immunotherapy for the treatment of colorectal cancer
    Review

    Lumish, M. A.; Cercek, A.
    Journal of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Predicting gemcitabine delivery by (18)F-FAC PET in murine models of pancreatic cancer
    Journal Article

    Russell, J.; Grkovski, M.; O'Donoghue, I. J.; Kalidindi, T. M.; Pillarsetty, N.; Burnazi, E. M.; Kulick, A.; Bahr, A.; Chang, Q.; LeKaye, H. C.; more...
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: Updated survival results and subgroup analyses from the BEACON study
    Journal Article

    Tabernero, J.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Wasan, H.; Yoshino, T.; Desai, J.; Ciardiello, F.; Loupakis, F.; Hong, Y. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save